Youjin Lu

576 total citations
20 papers, 398 citations indexed

About

Youjin Lu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Youjin Lu has authored 20 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in Youjin Lu's work include Pneumonia and Respiratory Infections (3 papers), Neonatal Respiratory Health Research (3 papers) and Sepsis Diagnosis and Treatment (3 papers). Youjin Lu is often cited by papers focused on Pneumonia and Respiratory Infections (3 papers), Neonatal Respiratory Health Research (3 papers) and Sepsis Diagnosis and Treatment (3 papers). Youjin Lu collaborates with scholars based in China and Saint Kitts and Nevis. Youjin Lu's co-authors include Jin Yang, Jianjun Jiang, Yongmei Jin, Mei Jing, Jiyu Cao, Yining Shi, Rong‐Yu Liu, Ying Wang, Cijiang Yao and Ying Liu and has published in prestigious journals such as PLoS ONE, Critical Care Medicine and Medicine.

In The Last Decade

Youjin Lu

20 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youjin Lu China 13 181 105 92 48 46 20 398
Yongmei Jin China 12 131 0.7× 74 0.7× 50 0.5× 45 0.9× 44 1.0× 37 416
Eli J. Finkelsztein United States 7 226 1.2× 139 1.3× 60 0.7× 41 0.9× 61 1.3× 11 421
Thomas Rimmelé France 12 233 1.3× 103 1.0× 52 0.6× 33 0.7× 48 1.0× 24 477
A. Tournoys France 11 204 1.1× 57 0.5× 74 0.8× 43 0.9× 66 1.4× 26 460
Marita Marengo Italy 11 77 0.4× 86 0.8× 86 0.9× 13 0.3× 73 1.6× 33 396
Sabitha Eppanapally United States 4 154 0.9× 226 2.2× 215 2.3× 34 0.7× 71 1.5× 6 573
Nikolaos Memos Greece 11 87 0.5× 93 0.9× 147 1.6× 22 0.5× 143 3.1× 26 451
Luís Tamayo Spain 4 277 1.5× 88 0.8× 41 0.4× 47 1.0× 47 1.0× 5 434
Thibaut Girardot France 7 191 1.1× 68 0.6× 32 0.3× 26 0.5× 46 1.0× 11 383

Countries citing papers authored by Youjin Lu

Since Specialization
Citations

This map shows the geographic impact of Youjin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youjin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youjin Lu more than expected).

Fields of papers citing papers by Youjin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youjin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youjin Lu. The network helps show where Youjin Lu may publish in the future.

Co-authorship network of co-authors of Youjin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Youjin Lu. A scholar is included among the top collaborators of Youjin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youjin Lu. Youjin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Jiayi, et al.. (2024). Serum SOD1 level predicts the severity and prognosis of community-acquired pneumonia patients. The American Journal of the Medical Sciences. 368(4). 311–319. 2 indexed citations
3.
Jiang, Jianjun, et al.. (2021). Role of ASM/Cer/TXNIP signaling module in the NLRP3 inflammasome activation. Lipids in Health and Disease. 20(1). 19–19. 22 indexed citations
4.
Shi, Yining, Yong‐Mei Jin, Fangfang Liu, et al.. (2021). Ceramide induces the apoptosis of non‑small cell lung cancer cells through the Txnip/Trx1 complex. International Journal of Molecular Medicine. 47(5). 13 indexed citations
5.
Zheng, Ling, Peng Cao, Chen Zhang, et al.. (2021). Serum S100A8 as an early diagnostic biomarker in patients with community-acquired pneumonia. Archives of Medical Science. 5 indexed citations
6.
Jiang, Jianjun, Jin Yang, Yining Shi, et al.. (2020). Head-to-head comparison of the diagnostic accuracy of Xpert MTB/RIF and Xpert MTB/RIF Ultra for tuberculosis: a meta-analysis. Infectious Diseases. 52(11). 763–775. 15 indexed citations
7.
Jin, Yongmei, et al.. (2019). Salvianolic acid B exerts a protective effect in acute liver injury by regulating the Nrf2/HO-1 signaling pathway. Canadian Journal of Physiology and Pharmacology. 98(3). 162–168. 20 indexed citations
8.
Jiang, Jianjun, Jin Yang, Mei Jing, Yongmei Jin, & Youjin Lu. (2018). Head-to-head comparison of qSOFA and SIRS criteria in predicting the mortality of infected patients in the emergency department: a meta-analysis. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 26(1). 56–56. 89 indexed citations
9.
Jiang, Jianjun, Jin Yang, Yongmei Jin, Jiyu Cao, & Youjin Lu. (2018). Role of qSOFA in predicting mortality of pneumonia. Medicine. 97(40). e12634–e12634. 34 indexed citations
10.
Wang, Ying, et al.. (2017). C2-ceramide influences alveolar epithelial barrier function by downregulating Zo-1, occludin and claudin-4 expression. Toxicology Mechanisms and Methods. 27(4). 293–297. 23 indexed citations
11.
Yang, Jin, Ying Wang, Cijiang Yao, et al.. (2016). Efficacy and Safety of Adjunctive Corticosteroids Therapy for Severe Community-Acquired Pneumonia in Adults: An Updated Systematic Review and Meta-Analysis. PLoS ONE. 11(11). e0165942–e0165942. 42 indexed citations
12.
Lu, Youjin, et al.. (2016). MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer. Tumor Biology. 37(9). 12685–12695. 34 indexed citations
14.
Yang, Jin, Zhengfei Yang, Youjin Lu, et al.. (2016). 1053: IMIPRAMINE IMPROVES ALVEOLAR EPITHELIAL BARRIER FUNCTION IN A MURINE ALI MODEL INDUCED BY LPS. Critical Care Medicine. 44(12). 339–339. 1 indexed citations
15.
Lu, Youjin, Jin Yang, Hui Liu, et al.. (2015). The association between osteopontin and survival in non-small-cell lung cancer patients: a meta-analysis of 13 cohorts. OncoTargets and Therapy. 8. 3513–3513. 13 indexed citations
16.
Liu, Hui, et al.. (2015). [Effect of C8-ceramide on apoptosis of alveolar type II epithelial cells].. PubMed. 38(6). 445–50. 2 indexed citations
17.
Liu, Ying, Yanyan Chen, Hui Liu, et al.. (2014). Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson’s disease: the impact of ethnicity and onset age. Neurological Sciences. 36(2). 179–188. 15 indexed citations
18.
Lu, Youjin, Jian Song, Dan Li, et al.. (2014). Recombinant tissue plasminogen activator for hemodynamically stable patients experiencing an acute pulmonary embolism: A meta-analysis. Thrombosis Research. 134(1). 50–56. 11 indexed citations
19.
Che, Zhen, Xiaoxia Zhu, Cijiang Yao, et al.. (2013). The association between the C-509T and T869C polymorphisms of TGF-β1 gene and the risk of asthma: A meta-analysis. Human Immunology. 75(2). 141–150. 15 indexed citations
20.
Lu, Youjin, et al.. (2009). [A case of lymphocytic leukemia complicated with Strongyloides stercoralis infection].. PubMed. 27(2). 139–139. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026